T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.55% |
| 2 | Healthcare | 16.29% |
| 3 | Consumer Discretionary | 15.56% |
| 4 | Financials | 12.85% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMK
1401
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $9.23M | ﹤0.01% |
395,472
+60,990
| +18% | +$1.48M |
|
1402
Urban Edge Properties
UE
$2.78B
| $9.18M | ﹤0.01% |
555,653
-229,656
| -29% | -$3.62M |
|
1403
Aramark
ARMK
$16.1B
| $9.12M | ﹤0.01% |
334,238
-37,380
| -10% | -$1.02M |
|
|
FTOC
1404
DELISTED
FTAC Olympus Acquisition Corp. Class A Ordinary Shares
FTOC
| $9.04M | ﹤0.01% |
+855,258
| New | +$10M |
|
1405
SolarEdge
SEDG
$1.98B
| $9M | ﹤0.01% |
31,308
+5,585
| +22% | +$1.68M |
|
1406
Markel Group
MKL
$22.8B
| $8.89M | ﹤0.01% |
7,802
-345
| -4% | -$372K |
|
|
OHPAU
1407
DELISTED
Orion Acquisition Corp. Unit
OHPAU
| $8.72M | ﹤0.01% |
+872,934
| New | +$8.75M |
|
1408
Arch Capital
ACGL
$33.2B
| $8.57M | ﹤0.01% |
223,428
-1,407
| -0.6% | -$50.1K |
|
1409
Wolfspeed
WOLF
$1.64B
| $8.54M | ﹤0.01% |
79,010
+11,553
| +17% | +$1.3M |
|
1410
HF Sinclair
DINO
$16.3B
| $8.53M | ﹤0.01% |
238,365
-16,449
| -6% | -$550K |
|
1411
Lyft
LYFT
$6.48B
| $8.49M | ﹤0.01% |
134,340
+30,175
| +29% | +$1.68M |
|
|
FRONU
1412
DELISTED
Frontier Acquisition Corp. Units
FRONU
| $8.47M | ﹤0.01% |
+853,365
| New | +$8.64M |
|
1413
Pliant Therapeutics
PLRX
$66.3M
| $8.42M | ﹤0.01% |
+214,157
| New | +$6.95M |
|
1414
Cheniere Energy
LNG
$55B
| $8.26M | ﹤0.01% |
114,686
+14,428
| +14% | +$986K |
|
|
EPZM
1415
DELISTED
Epizyme, Inc
EPZM
| $8.19M | ﹤0.01% |
940,231
-602,356
| -39% | -$6.23M |
|
|
BLSA
1416
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
| $8.18M | ﹤0.01% |
774,136
| – | – |
|
1417
MoonLake Immunotherapeutics
MLTX
$1.4B
| $8.11M | ﹤0.01% |
792,285
+4,500
| +0.6% | +$49.6K |
|
1418
Grand Canyon Education
LOPE
$3.79B
| $7.98M | ﹤0.01% |
74,517
+206
| +0.3% | +$20.5K |
|
|
EUCRU
1419
DELISTED
Eucrates Biomedical Acquisition Corp. Unit
EUCRU
| $7.94M | ﹤0.01% |
786,890
+20,300
| +3% | +$216K |
|
|
VMW
1420
DELISTED
VMware, Inc
VMW
| $7.59M | ﹤0.01% |
50,429
+3,011
| +6% | +$430K |
|
1421
Arcturus Therapeutics
ARCT
$223M
| $7.56M | ﹤0.01% |
183,069
-1,239,110
| -87% | -$73.9M |
|
1422
Ranger Energy Services
RNGR
$405M
| $7.47M | ﹤0.01% |
1,363,569
| – | – |
|
1423
Berkshire Hathaway Class A
BRK.A
$1.09T
| $7.33M | ﹤0.01% |
19
| – | – |
|
1424
Arcosa
ACA
$7.12B
| $7.31M | ﹤0.01% |
112,367
+63,682
| +131% | +$3.91M |
|
1425
RB Global
RBA
$16B
| $7.27M | ﹤0.01% |
124,102
-5
| -0% | -$293 |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.